Rapid Test Kit QuickVue® Professional Use SARS Antigen Nasal Swab Sample 25 Tests

Product Information

Specifications for Rapid Test Kit QuickVue® Professional Use SARS Antigen Nasal Swab Sample 25 Tests

Manufacturer	Quidel
Part Number	20387
Application	Rapid Test Kit
Brand	QuickVue® Professional Use
Contents 1	(25) Individually Packaged Test Strips, (25) Reagent Tubes, (25) Vials of Reagent Solution with 340 µL Salt Solution, (25) Sterile Nasal Swabs, SARS Positive Control Swab, Negative Control Swab, Package Insert, and Procedure Card
HCPCS	U0002
Number of Tests	25 Tests
Reading Type	Visual Read
Sample Type	Nasal Swab Sample
Test Format	Test Strip Format
Test Method	Lateral Flow Method
Test Name	SARS Antigen
Time to Results	10 Minute Results
UNSPSC Code	41116126

Product Properties:

Laboratories within the United States and its territories are required to report all results to the appropriate public health authorities
Product ships from McKesson with minimum 30 days dating
Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status; positive results do not rule out bacterial infection or co-infection with other viruses
Negative results should be treated as presumptive and confirmation with a molecular assay, if necessary, for patient management, may be performed; negative results do not rule out COVID-19 and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions
The QuickVue SARS Antigen test does not differentiate between SARS-CoV and SARS-CoV-2
For use under an Emergency Use Authorization (EUA) only: https://www.fda.gov/medical-devices/emergency-situations-medical-devices/emergency-use-authorizations
Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high or waived complexity tests; this test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation
Each kit contains everything needed to perform the test, including Nasal Swabs and positive and negative controls
Please see attached letter for detailed information on a 1 year extension on expiration dating
The QuickVue SARS Antigen test is intended for use by trained clinical laboratory personnel and individuals trained in point of care settings
Simple workflow follows a similar format to CLIA-waved QuickVue assays, just sample, dip, and read
Accurate detection with direct anterior nares swab samples: 96.6% PPA and 99.3% NPA
The QuickVue SARS Antigen Test is a lateral flow immunoassay that allows for the rapid, qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in anterior nares (NS) swab specimens directly from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms
Negative results should be considered in the context of a patient’s recent exposures, history and the presence of clinical signs and symptoms consistent with COVID-19

Rapid Test Kit QuickVue® Professional Use SARS Antigen Nasal Swab Sample 25 Tests

Rapid Test Kit QuickVue® Professional Use SARS Antigen Nasal Swab Sample 25 Tests

Application

Brand

Contents 1

Depth

Dimension Uom

Freight Class

HCPCS

Height

Number of Tests

Order from

Product Dating

Reading Type

Related Products Identifier

Related Products Name

Sample Type

Test Format

Test Method

Test Name

Time to Results

UNSPSC Code

Unit Volume

Unit Weight

Volume Uom

Weight Uom

Width

Specifications for Rapid Test Kit QuickVue® Professional Use SARS Antigen Nasal Swab Sample 25 Tests

Newsletter Signup: